TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 NOK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
609
|
607
|
684 |
| Financial expenses |
11
|
0
|
47 |
| Earnings before taxes |
557
|
73
|
61 |
| EBITDA |
-25
|
-4
|
107 |
| Total assets |
3,590
|
3,143
|
3,207 |
| Current assets |
227
|
400
|
290 |
| Current liabilities |
294
|
272
|
173 |
| Equity capital |
3,170
|
2,738
|
2,868 |
| - share capital |
106
|
100
|
99 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
88.3%
|
87.1%
|
89.4% |
| Turnover per employee |
607
|
684 | |
| Profit as a percentage of turnover |
91.5%
|
12.0%
|
8.9% |
| Return on assets (ROA) |
15.8%
|
2.3%
|
3.4% |
| Current ratio |
77.2%
|
147.1%
|
167.6% |
| Return on equity (ROE) |
17.6%
|
2.7%
|
2.1% |
| Change turnover |
-33
|
-86
|
-417 |
| Change turnover % |
-5%
|
-12%
|
-38% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.